English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines? Journal article
Huang, Cong, Ung, Carolina Oi Lam, Wushouer, Haishaerjiang, Bai, Lin, Huang, Tao, Li, Xinyi, Guan, Xiaodong, Shi, Luwen. Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?[J]. Health Research Policy and Systems, 2022, 20(1), 3.
Authors:  Huang, Cong;  Ung, Carolina Oi Lam;  Wushouer, Haishaerjiang;  Bai, Lin;  Huang, Tao; et al.
Favorite | TC[WOS]:10 TC[Scopus]:12  IF:3.6/4.3 | Submit date：2022/05/13
Health Technology Assessment  Pricing Negotiation  Targeted Anticancer Medicines  
Seizing the strategic opportunities of emerging technologies by building up innovation system: Monoclonal antibody development in China Journal article
Zhang M.-Y., Li J., Hu H., Wang Y.-T.. Seizing the strategic opportunities of emerging technologies by building up innovation system: Monoclonal antibody development in China[J]. Health Research Policy and Systems, 2015, 13(1).
Authors:  Zhang M.-Y.;  Li J.;  Hu H.;  Wang Y.-T.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:3.6/4.3 | Submit date：2018/10/31
China  Emerging Technology  Innovation System  Monoclonal Antibody  
Public funding and private investment for R&D: a survey in China’s pharmaceutical industry Journal article
Qiu, Lan, Chen, Zi-Ya, Lu, Deng-Yu, Hu, Hao, Wang, Yi-Tao. Public funding and private investment for R&D: a survey in China’s pharmaceutical industry[J]. HEALTH RESEARCH POLICY AND SYSTEMS, 2014, 12(27), 27.
Authors:  Qiu, Lan;  Chen, Zi-Ya;  Lu, Deng-Yu;  Hu, Hao;  Wang, Yi-Tao
Favorite | TC[WOS]:26 TC[Scopus]:23  IF:3.6/4.3 | Submit date：2018/11/01
Pharmaceutical Industry  Private Investment  Public Funding  Research And Development